Established FBXL13 as a functional SCF E3 ligase substrate receptor and identified CEP192 as its degradation target, defining how FBXL13 restrains centrosomal microtubule nucleation and cell motility.
Evidence Co-IP, proteasomal degradation assays, and overexpression/knockdown with γ-tubulin and CEP192 quantification plus motility assays in cultured cells
- Degron/recognition motif on CEP192 not mapped
- Functional roles of Centrin-2/Centrin-3/CEP152 interactions not resolved
- In vivo requirement for centrosomal function not tested in animals